A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
作者信息
Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K
出版信息
EMBO J. 1996 Apr 1;15(7):1751.
Abstract
摘要
相似文献
1
2
3
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.由orf病毒编码的一种新型血管内皮生长因子VEGF-E，通过VEGFR-2（KDR）而非VEGFR-1（Flt-1）受体酪氨酸激酶发出的信号介导血管生成。
EMBO J. 1999 Jan 15;18(2):363-74. doi: 10.1093/emboj/18.2.363.
4
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.对照和糖尿病大鼠眼中的血管内皮生长因子及其受体
Lab Invest. 1998 Aug;78(8):1017-27.
5
Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.高氧暴露家兔视网膜血管内皮生长因子及其受体的调控
Invest Ophthalmol Vis Sci. 2002 May;43(5):1546-57.
6
Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.利用一种针对血管内皮生长因子（VEGF）激酶受体（fms样酪氨酸激酶受体和含激酶插入结构域的受体）的双功能双抗体完全抑制VEGF活性。
Cancer Res. 2001 Oct 1;61(19):7002-8.
7
Proteolytic processing regulates receptor specificity and activity of VEGF-C.蛋白水解加工调节VEGF-C的受体特异性和活性。
EMBO J. 1997 Jul 1;16(13):3898-911. doi: 10.1093/emboj/16.13.3898.
8
Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.一种噬菌体衍生肽拮抗剂与血管内皮生长因子复合物的溶液结构
J Mol Biol. 2002 Feb 22;316(3):769-87. doi: 10.1006/jmbi.2001.5370.
9
10
Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.血管内皮生长因子（VEGF）及其两种特异性受体Flt-1和KDR在猪胎盘和非妊娠子宫中的免疫组织化学定位。
Placenta. 1999 Jan;20(1):35-43. doi: 10.1053/plac.1998.0350.
引用本文的文献
1
Fc-Elabela mitigates heart failure without liver and renal toxicity in mice.Fc-埃拉贝拉可减轻小鼠心力衰竭，且无肝毒性和肾毒性。
Front Pharmacol. 2025 Jul 14;16:1555728. doi: 10.3389/fphar.2025.1555728. eCollection 2025.
2
Meningeal lymphatic drainage: novel insights into central nervous system disease.脑膜淋巴引流：对中枢神经系统疾病的新见解。
Signal Transduct Target Ther. 2025 May 5;10(1):142. doi: 10.1038/s41392-025-02177-z.
3
Regulation of VEGFR3 signaling in lymphatic endothelial cells.淋巴管内皮细胞中VEGFR3信号通路的调控
Front Cell Dev Biol. 2025 Feb 13;13:1527971. doi: 10.3389/fcell.2025.1527971. eCollection 2025.
4
sVEGFR3 alleviates myocardial ischemia/reperfusion injury through regulating mitochondrial homeostasis and immune cell infiltration.可溶性血管内皮生长因子受体3通过调节线粒体稳态和免疫细胞浸润减轻心肌缺血/再灌注损伤。
Apoptosis. 2025 Apr;30(3-4):894-911. doi: 10.1007/s10495-024-02068-8. Epub 2025 Jan 25.
5
The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease.淋巴管内皮细胞代谢在淋巴管生成和疾病中的作用。
Front Cardiovasc Med. 2024 May 9;11:1392816. doi: 10.3389/fcvm.2024.1392816. eCollection 2024.
6
Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner.达鲁胺通过以依赖 FLT4 的方式调节 PTEN/AKT/mTOR 和 Ras/MEK1/2/ERK1/2 通路抑制非小细胞肺癌的发展。
Curr Cancer Drug Targets. 2024;24(11):1157-1168. doi: 10.2174/0115680096282997240101192452.
7
Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets.淋巴管：起源、异质性、生物学功能和治疗靶点。
Signal Transduct Target Ther. 2024 Jan 3;9(1):9. doi: 10.1038/s41392-023-01723-x.
8
Biology and therapeutic targeting of vascular endothelial growth factor A.血管内皮生长因子 A 的生物学和治疗靶向。
Nat Rev Mol Cell Biol. 2023 Nov;24(11):816-834. doi: 10.1038/s41580-023-00631-w. Epub 2023 Jul 25.
9
Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy.重新思考药物递送系统在新生血管性年龄相关性黄斑变性治疗中的潜力和必要性。
Front Bioeng Biotechnol. 2023 May 23;11:1199922. doi: 10.3389/fbioe.2023.1199922. eCollection 2023.
10
Acquired lymphedema: Molecular contributors and future directions for developing intervention strategies.获得性淋巴水肿：分子影响因素及制定干预策略的未来方向。
Front Pharmacol. 2022 Oct 25;13:873650. doi: 10.3389/fphar.2022.873650. eCollection 2022.
Zotero 插件